Detailing its extensive history of advocacy targeted at drug companies with the goal of lowering drug prices and increasing access to affordable HIV/AIDS medications, the letter ends with a challenge to Cipla to demonstrate the same sort of commitment to affordable drug access in for Indians in need as it does for Africa: "AHF is prepared to meet with Cipla anywhere, at any time to find a solution. The rest is up to Cipla."
To view the open letter print ad in its entirety, please visit: http://www.aidshealth.org/images/pdfs/ciplaad2thehinduweb2.pdf
History of AIDS Healthcare Foundation's Drug Pricing and Access Advocacy
Over the years AHF has had a long, outspoken and successful history of advocacy and outreach regarding AIDS drug pricing and access issues around the globe. This advocacy has often occurred via direct meetings and correspondence with drug company officials; through press conferences and press statements; via the filing of lawsuits; through lobbying government officials; via the mounting of protests and awareness campaigns; and through the placement of advertisements and calls to action, such as the current, "Profits at What Costs? AIDS Drugs for All," in India.
AHF's advocacy efforts have included:
-- Earlier this year, AHF mounted a similar print ad and awareness
campaign on AIDS drug pricing in Mexico. That campaign featured a print
ad, "AIDS Drug Prices to Die For," which ran in prominent papers in
Mexico and several US cities and targeted both Bristol Myers-Squibb
(BMS) and Merck (known as Merck Sharp & Dohme in Mexico). The two drug
companies are being targeted for charging four times as much in Mexico
for
'/>"/>
| SOURCE AIDS Healthcare Foundation Copyright©2007 PR Newswire. All rights reserved |